Pull to refresh
Logo
Utah approves first AI system to issue initial prescriptions

Utah approves first AI system to issue initial prescriptions

New Capabilities

Nolla Health's Nolla Derm app prescribes acne treatments without a prior office visit

Yesterday: Nolla Health receives first U.S. approval for AI-issued initial prescriptions

Overview

Updated Yesterday

A Utah resident with acne can now get a prescription without seeing a doctor. On October 5, Nolla Health received the first U.S. regulatory approval for an AI system to issue initial prescriptions, not just refills.

The Nolla Derm app scans the user's face, analyzes acne severity, and selects from eight pre-approved treatment pathways. The pilot runs for a year with physician oversight that loosens in stages, from full review of every prescription to monthly sampling.

Why it matters

If the pilot works, AI prescribing could expand beyond acne to other routine conditions, changing who writes prescriptions and how patients access care.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$4.99
Monthly subscription cost
Discounted rate for Utah residents opting into the Nolla Derm pilot.
96%
Clinician agreement with AI recommendations
Licensed clinicians agreed with the AI's treatment choices in over 96% of real-world cases.
8
Skin treatments AI can prescribe
The AI selects only from pre-approved treatment pathways for mild-to-moderate acne.
3
Physician oversight stages
Oversight loosens from full review of every prescription to monthly sampling as safety targets are met.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

2026 October 2026

2 events Latest: Yesterday
  1. Nolla Health receives first U.S. approval for AI-issued initial prescriptions

    Latest Regulatory

    Utah's Office of Artificial Intelligence authorized Nolla Health's AI to issue initial acne prescriptions through the Nolla Derm app, the first such approval in the country.

  2. Utah allows AI to renew certain medications

    Regulatory

    Utah began permitting AI systems to renew certain medications, a precursor to the Nolla Health approval.

Scenarios

1

Nolla Derm expands to new conditions beyond acne

Possible Resolves by Oct 5, 2027

Discussed by: Nolla Health has said acne is the right starting point for AI in healthcare, implying other routine conditions could follow.

If the pilot meets safety targets, Nolla Health could seek approval for additional low-risk conditions. The company has described acne as a well-understood, low-risk condition with decades of clinical evidence, suggesting a template for other routine dermatology or primary care cases.

2

Utah suspends AI prescription pilot after safety concerns

Unlikely Resolves by Oct 5, 2027

Discussed by: The pilot's staged oversight and safety targets suggest regulators are monitoring closely for adverse events.

If the AI issues a harmful prescription or misses safety targets, the Utah Office of AI Policy could suspend the program. The pilot requires 95% agreement with physicians and zero serious adverse events to advance between oversight stages.

3

Pilot completes first year, renews for two more

Likely Resolves by Oct 5, 2027

Discussed by: The program is structured to operate for a year with potential renewal at the discretion of the Utah Office of AI Policy.

If the pilot meets safety targets and shows strong clinical performance, the Utah Office of AI Policy could renew the program for two additional years. The renewal decision rests with the office that authorized the pilot.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

March 2020

Telemedicine waivers during COVID-19 (2020)

At the start of the pandemic, the federal government and states waived requirements that doctors see patients in person before prescribing. Medicare began paying for telehealth visits at the same rate as in-person visits.

Then

Telehealth use surged during the pandemic and remained elevated afterward.

Now

Many states made telehealth waivers permanent, expanding remote healthcare access.

Why this matters now

Like the telehealth waivers, Utah's approval of AI prescribing relaxes a long-standing requirement that a licensed physician issue prescriptions, to expand access to care.

September 2014

First autonomous vehicle testing permits (California, 2014)

California's Department of Motor Vehicles began issuing permits for companies to test autonomous vehicles on public roads, creating a regulatory framework for a technology with no clear legal path to deployment.

Then

Companies including Google and Tesla began testing autonomous vehicles in California.

Now

Other states followed with their own frameworks, and autonomous vehicle testing expanded nationwide.

Why this matters now

Utah's approach to AI prescribing mirrors this pattern: a state creating a controlled regulatory framework for a new technology, with other states likely to follow.

Sources

(10)